The Latest Cardiac and Vascular News
PALM SPRINGS, Calif. and MOUNTAIN VIEW, Calif., March 31, 2022 /PRNewswire/ — Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, and Lark Health today announced that DOHC will offer Lark Heart Health, a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD). Together, DOHC and Lark will […]
Excluding certain non-recurring items, the net profit attributable to owners of the Company increased by 76.8% to RMB 324.0million SHENZHEN, China, March 30, 2022 /PRNewswire/ — LifeTech Scientific Corporation (LifeTech, 1302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 annual results. During the year ended 31 December 2021, […]
Through Save Legs. Change Lives.™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease TITUSVILLE, N.J., March 31, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year […]
New clinical data shows Cardiologs’ deep learning model can predict the short-term risk of atrial fibrillation (AFib) based on 24-hour Holter recordings that show normal sinus rhythm PARIS and BOSTON, March 31, 2022 /PRNewswire/ — Cardiologs today announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in Washington, DC, from April 2-4, 2022. The […]
Transparent 3D models allow MedTech companies to train physicians on new devices outside the cath lab BOSTON, March 31, 2022 /PRNewswire/ — Biomodex®, the leader in biorealistic haptic simulators for physician training and rehearsals, today announced the launch of Clear Cartridges for use with all Biomodex EVIAS™ and EVIAS Plus™ stations. The anatomically accurate clear cartridges […]
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. REGULATED INFORMATION – INSIDE INFORMATION LIÈGE, Belgium, March 31, 2022 (GLOBE NEWSWIRE) — Hyloris Pharmaceuticals SA (Euronext Brussels: […]
Shockwave M5+ IVL Catheter Broadens Options for Treatment of Peripheral Arteries SANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the global commercial availability of the Shockwave M5+ peripheral […]
Innovations designed to seamlessly work together, strengthen clinical confidence, build efficiency throughout the care pathway, and improve cardiac care experiences Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new additions to its innovative integrated portfolio of cardiology solutions at the American College […]
PARIS, March 31, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announced the publication of a new scientific article reporting the efficacy of its second drug-candidate, […]
WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided key business updates. “This past quarter […]
